Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

45 results about "Thioanisole" patented technology

Thioanisole is an organic compound with the formula CH₃SC₆H₅. It is a colorless liquid that is soluble in organic solvents. It is the simplest alkyl–aryl thioether. The name indicates that this compound is the sulfur analogue—the thioether rather than the oxygen-centered ether—of anisole.

Method for continuously preparing 2-aryl-benzothiophene/furan compound by utilizing electrochemical micro-channel reaction device

The invention discloses a method for continuously preparing a 2-aryl-benzothiophene / furan compound by utilizing an electrochemical micro-channel reaction device. The preparation method comprises the following steps: dissolving ethynyl thioanisole / phenylethynyl anisole and an iodine-containing electrolyte in water and acetonitrile to prepare a homogeneous solution, then introducing the prepared homogeneous solution into a feeding hole of an electrochemical micro-channel reaction device by utilizing an injection pump in single-strand sample introduction, and reacting under the action of a direct-current power supply to obtain the product 2-aryl-benzothiophene / furan compound; wherein the electrochemical micro-channel reaction device comprises an anode electrode, a cathode electrode, an electrolytic tank bracket, a reaction tank, the direct-current power supply and a temperature control module; wherein the reaction tank is positioned between the anode electrode and the cathode electrode, and a closed serpentine flow path is formed between the anode electrode and the cathode electrode; the anode electrode and the cathode electrode are arranged on the electrolytic tank bracket; one endsof the anode electrode and the cathode electrode are connected with each other and are connected with the direct-current power supply; and the temperature control module is embedded in the electrolytic tank bracket and is used for controlling the temperature of liquid in the reaction tank.
Owner:NANJING UNIV OF TECH

Chiral catalytic synthesis method of thiamphenicol

The invention relates to a chiral catalytic synthesis method of thiamphenicol which is a chloramphenicol broad-spectrum antibiotic. Thioanisole serves as an initating raw material, acylation and bromo are achieved, nitrogen iridine containing substituent groups is synthetized, and a qualified product which meets the requirement of drug administration is synthetized through chiral catalytic reduction, oxidizing reaction, acidification loop opening, deprotection and acylation reaction. The chiral catalytic reduction includes that under the action of a catalyst trans-RuC12[(R)-xylbinap][(S)-DPEN], [1-substituent group nitrogen iridine-2-group] [4-(methylthio group) phenyl group] ketone is subjected to hydrogenation reduction to obtain [1-substituent group nitrogen iridine-2-group] [4-(methylthio group) phenyl group] ketone with a high ee value and a high de value. D-methylsulfonylphenyl serine ethyl ester used in industrial production serves as a raw material to synthetize the thiamphenicol, the D-methylsulfonylphenyl serine ethyl ester is obtained through chemical chiral resolution by using a racemic compound, and the other half of the raw material is wasted. According to the unsymmetrical chiral catalytic dynamic reduction method, waste of the other half of the raw material is avoided, the utilization rate of a material is improved, and the production cost is reduced.
Owner:MASTEAM BIO TECH

Preparation method of antitumor small peptides FpAT

The invention relates to a preparation method of antitumor small peptides FpAT. A technical scheme is characterized in that the preparation method comprises the following steps: adopting Fmoc/tBu solid-phase peptide synthesis technique and adopting 2-chlorotrityl chloride resin (CTC Resin) as a carrier to prepare Fmoc-Arg(Pbf)-CTC Resin having a substitutivity of 0.4-0.7mmol/g; sequentially condensing Fmoc protected amino acids having a sequence from the C-terminal to the N-terminal of FpAT through the solid-phase peptide synthesis technique until the condensation of the N-terminated aspartic acid is completed to obtain an FpAT fully-protected peptide resin; obtaining crude FpAT peptides through using a TFA/thioanisole/EDT/anisole as a cracking reagent and settling with anhydrous ether; and adding water to the crude FpAT peptides for dissolving, adjusting the pH value to 3-4, purifying through using preparative reverse phase HPLC, collecting a target product having a qualified purify, and lyophilizing to obtain the finished antitumor small peptides FpAT. The preparation method has the advantages of simple operation, high production efficiency, low equipment requirement, total yield reaching above 35%, realization of the large-scale production, and good economic and social values and application prospect.
Owner:苏州中科天马肽工程中心有限公司

Metalloporphyrin@metal organic framework material heterogeneous photosensitizer as well as preparation method and application thereof

The invention discloses a heterogeneous photosensitizer based on a metal organic framework material as a carrier as well as a preparation method and application of the heterogeneous photosensitizer, and belongs to the technical field of preparation of environment-friendly functional composite materials. The heterogeneous photosensitizer disclosed by the invention is a metalloporphyrin@ZIF-8 composite material, wherein a metalloporphyrin compound which has strong absorption in a visible light region and can efficiently generate singlet oxygen (1O2) is loaded into a ZIF-8 metal organic framework material pore channel through a simple "one-pot" self-assembly method. Finally, the prepared heterogeneous photosensitizer is used for catalytic oxidation of thioanisole, then the catalyst can be recycled through simple centrifugation, washing and drying, and the heterogeneous photosensitizer is circularly used for catalytic oxidation of thioanisole and degradation of bisphenol A. The preparation method is simple, easy to operate, environmentally friendly, low in cost, good in repeatability and short in consumed time; the heterogeneous photosensitizer has strong absorption in a visible region, and 1O2 can be efficiently generated, so that thioether compounds can be selectively oxidized into sulfoxide under the condition of stirring at room temperature, the conversion rate is high, and the reusability is good.
Owner:PINGDINGSHAN UNIVERSITY

Solid Phase Fragment Synthesis of Thymosin α1

The invention discloses a synthesis technology of thymosin alpha1, which comprises the following steps: synthesizing multiple segments according to the difficult-synthesis sequence of thymosin alpha1, wherein a solid-phase segment condensation method is adopted for the area of difficult sequences so as to improve the synthesis quality and shorten the synthesis time, and a conventional step-by-step condensation method is adopted for the area of easy-synthesis sequences; obtaining all-protected thymosin alpha1 peptide resin on Wang Resin; cracking the peptide resin to obtain crude peptide by taking TFA / m-cresol or TFA / thioanisole / EDT / anisole as a cracking reagent; dissolving the crude peptide and filtering; and performing preparative reversed phase HPLC purification, desalting, rotary evaporation and freeze drying to obtain a finished product of thymosin alpha1 of which the purity can exceed 99%. According to the technology disclosed by the invention, the purity of the synthesized crude peptide can reach about 80%, the purification is easy, and the total yield can reach 30%. The total yield and product quality of thymosin alpha1 produced by the method disclosed by the invention are both much remarkably improved than those of other methods reported in documents; and moreover, the production cycle can be shortened by 40-50%, the production cost is reduced, and the method is suitable for large-scale preparation of high-purity thymosin alpha1.
Owner:苏州天马医药集团天吉生物制药有限公司

Chiral catalytic synthesis method of thiamphenicol

The invention relates to a chiral catalytic synthesis method of thiamphenicol which is a chloramphenicol broad-spectrum antibiotic. Thioanisole serves as an initating raw material, acylation and bromo are achieved, nitrogen iridine containing substituent groups is synthetized, and a qualified product which meets the requirement of drug administration is synthetized through chiral catalytic reduction, oxidizing reaction, acidification loop opening, deprotection and acylation reaction. The chiral catalytic reduction includes that under the action of a catalyst trans-RuC12[(R)-xylbinap][(S)-DPEN], [1-substituent group nitrogen iridine-2-group] [4-(methylthio group) phenyl group] ketone is subjected to hydrogenation reduction to obtain [1-substituent group nitrogen iridine-2-group] [4-(methylthio group) phenyl group] ketone with a high ee value and a high de value. D-methylsulfonylphenyl serine ethyl ester used in industrial production serves as a raw material to synthetize the thiamphenicol, the D-methylsulfonylphenyl serine ethyl ester is obtained through chemical chiral resolution by using a racemic compound, and the other half of the raw material is wasted. According to the unsymmetrical chiral catalytic dynamic reduction method, waste of the other half of the raw material is avoided, the utilization rate of a material is improved, and the production cost is reduced.
Owner:MASTEAM BIO TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products